Effect of hypertonic saline infusion versus normal saline on serum NGAL and cystatin C levels in patients undergoing coronary artery bypass graft

Journal of Tehran University Heart Center

Volumn 8, Issue 1, 2013, Pages 21-27

  Yousefshahi, Fardin ^a   Bashirzadeh, Mona ^b   Abdollahi, Mohammad ^c   Mojtahedzadeh, Mojtaba ^c   Salehiomran, Abbass ^a   Jalali, Arash ^a   Mazandarani, Mahnaz ^c   Zaare, Elmira ^a   Ahadi, Mehdi ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute, kidney injury; Coronary artery bypass; Cystatin C; Neutrophil gelatinase associated lipocalin protein, rat; Saline solution, hypertonic

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; GLUCOSE; MAGNESIUM; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; POTASSIUM; SODIUM; SODIUM CHLORIDE;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HEMATOCRIT; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAAORTIC BALLOON PUMP; IRAN; MAGNESIUM BLOOD LEVEL; MALE; MORTALITY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PREOPERATIVE CARE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; THROMBOCYTE;

EID: 84874548468     PISSN: 17358620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chertow GM, Soroko SH, Paganini EP, Cho KC, Himmelfarb J, Ikizler TA, Mehta RL. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int 2006;70:1120-1126.
2. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-3370.
3. Liaño F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996;50:811-818.
4. Cho KC, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM. Survival by dialysis modality in critically ill patients with acute kidney injury. J Am Soc Nephrol 2006;17:3132-3138.
5. Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008;23:1970-1974.
6. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-348.
7. Lok CE, Austin PC, Wang H, Tu JV. Impact of renal insufficiency on short and long-term outcomes after cardiac surgery. Am Heart J 2004;148:430-438.
8. Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, Newgard C, Slutsky A, Coimbra R, Emerson S, Minei JP, Bardarson B, Kudenchuk P, Baker A, Christenson J, Idris A, Davis D, Fabian TC, Aufderheide TP, Callaway C, Williams C, Banek J, Vaillancourt C, van Heest R, Sopko G, Hata JS, Hoyt DB; ROC Investigators. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA 2010;304:1455-1464.
9. Wigginton JG, Roppolo L, Pepe PE. Advances in resuscitative trauma care. Minerva Anestesiol 2011;77:993-1002.
10. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure -definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-212.
11. Devarajan P. Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn 2008;2:387-398.
12. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-1605.
13. Böken Kamp A, Ozden N, Dieterich C, Schumann G, Ehrich JH, Brodehl J. Cystatin C and creatinine after successful kidney transplantation in children. Clin Nephrol 1999;52:371-376.
14. Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, Philipp T, Kribben A. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115-1122.
15. Krawczeski CD, Vandevoorde RG, Kathman T, Bennett MR, Woo JG, Wang Y, Griffiths RE, Devarajan P. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. Clin J Am Soc Nephrol 2010;5:1552-1557.
16. Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 2009;37:553-560.
17. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-1238.
18. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148:810-819.
19. Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009;53:261-266.
20. Azoubel G, Nascimento B, Ferri M, Rizoli S. Operating room use of hypertonic solutions: a clinical review. Clinics (Sao Paulo) 2008;63:833-840.
21. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004;32:755-759.
22. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994;269:16712-16719.
23. DuBose JJ, Kobayashi L, Lozornio A, Teixeira P, Inaba K, Lam L, Talving P, Branco B, Demetriades D, Rhee P. Clinical experience using 5% hypertonic saline as a safe alternative fluid for use in trauma. J Trauma 2010;68:1172-1177.
24. Kerwin AJ, Schinco MA, Tepas JJ, 3rd, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma 2009;67:277-282.
25. Oddo M, Levine JM, Frangos S, Carrera E, Maloney-Wilensky E, Pascual JL, Kofke WA, Mayer SA, Le Roux PD. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry 2009;80:916-920.
26. Bulger EM, Tower CM, Warner KJ, Garland T, Cuschieri J, Rizoli S, Rhind S, Junger WG. Increased neutrophil adenosine a3 receptor expression is associated with hemorrhagic shock and injury severity in trauma patients. Shock 2011;36:435-439.
27. Rizoli SB, Rhind SG, Shek PN, Inaba K, Filips D, Tien H, Brenneman F, Rotstein O. The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg 2006;243:47-57.
28. Zhu GC, Quan ZY, Shao YS, Zhao JG, Zhang YT. The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Zhongguo Wei Zhong Bing JiJiu Yi Xue 2011;23:150-153.
29. Vincenzi R, Cepeda LA, Pirani WM, Sannomyia P, Rocha-E-Silva M, Cruz RJ, Jr. Small volume resuscitation with 3% hypertonic saline solution decrease inflammatory response and attenuates end organ damage after controlled hemorrhagic shock. Am J Surg 2009;198:407-414.
30. Sirieix D, Hongnat JM, Delayance S, D'Attellis N, Vicaut E, Bérrébi A, Paris M, Fabiani JN, Carpentier A, Baron JF. Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Crit Care Med 1999;27:2159-2165.
31. Prien T, Thülig B, Wüsten R, Schoofs J, Weyand M, Lawin P. Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses. ZentralblChir 1993;118:257-263.
32. Järvelä K, Kaukinen S. Hypertonic saline (7.5%) after coronary artery bypass grafting. Eur J Anaesthesiol 2001;18:100-107.
33. L. NGAL: a marker molecule for the distressed kidney. Clin Lab Internat 2005;29:39-41. http://www.cli-online.com/fileadmin/artimg/ngal-a-marker-molecule-for-the-distressedkidney.pdf (20 February 2012).
34. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A; NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012-1024.
35. Uttenthal L. NGAL: how useful is the new marker of kidney damage? Clin Lab Internat 2007;32:36-40. http://www.cli-online.com/fileadmin/artimg/ngal-how-useful-is-the-new-marker-ofkidney-damage.pdf (20 February 2012).